Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2016-03-17, 15:06:18 | version 1.45.01
7 With the approval of an Attract Group on the topic “Organ-on-a-Chip”, we are pursuing new and commercially relevant technologies in the field of health research In March , r Peter Loskill, a physicist who was successfully recruited from UC Berkeley, will begin new projects in the Department of Cell and Tissue Engineering at Fraunhofer IGB. With the new research train- ing group “3D Infect” at the University of Würzburg, infection research will be strengthened at Fraunhofer IGB. Our Würzburg branch is focusing on the development of three-dimensional human infection tissues models. In addition, we are spinning out two startup companies based on our groundbreaking research in the medicine business area. The recruitment process is underway to find a successor for Professor irth that will assume the position as director of Fraunhofer IGB and of the Institute of Interfacial Process Engineering and Plasma Technology (IGVP) at the University of Stuttgart. The time ahead for us is one of transition and change. We are aware of our responsibility to our employees, business partners and grant donors e want raunhofer I B to carry on in its path to scientific e cellence and economic success. To succeed, we are currently revising our strategic direction to future market and customer requirements. We thank our customers and partners for the trust-based cooperation in the past year and look forward to the challenges ahead. We wish you pleasant reading and hope that this annual report may inspire ideas that you can include in your work and for further cooperation with Fraunhofer IGB. We are looking forward to an exciting, successful and productive future with you. Katja Schenke-Layland Christian Oehr